Triterpenoid Therapeutics (TTX) Email Formats

Research Services • Lebanon, New Hampshire, United States • 1-10 Employees

Triterpenoid Therapeutics (TTX) Email Formats

Triterpenoid Therapeutics (TTX) uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@triterptx.com), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@triterptx.com	100%

Key Contact at Triterpenoid Therapeutics (TTX)

Paul E. Sporn

Co-Founder and Managing Director

Company overview

Headquarters	16 Cavendish Court, Lebanon, New Hampshire 03766, US
Website	triterptx.com
NAICS	5417
Founded	2018
Employees	1-10

About Triterpenoid Therapeutics (TTX)

Triterpenoid Therapeutics (TTX) is developing brain-penetrant therapeutics that target root rivers of neurodegenerative diseases and brain cancers, conditions that have resisted treatment for decades. A significant overlap of the NLRP3 Inflammasome and cellular Integrated Stress Response drives disease progression across multiple conditions, including neurodegenerative diseases and brain cancer. Understanding this interaction opens new therapeutic opportunities and is the focus of TTX’s efforts to improve patient outcomes.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Triterpenoid Therapeutics (TTX) has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Triterpenoid Therapeutics (TTX) has never raised funding before.

Triterpenoid Therapeutics (TTX) Tech Stack

Discover the technologies and tools that power Triterpenoid Therapeutics (TTX)'s digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

reCAPTCHA

Security

Squarespace Commerce

Ecommerce

GoDaddy

Hosting

Stimulus

JavaScript frameworks

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Cart Functionality

Ecommerce

Frequently asked questions

Triterpenoid Therapeutics (TTX) is located in Lebanon, New Hampshire, US.

Triterpenoid Therapeutics (TTX) was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Triterpenoid Therapeutics (TTX) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Triterpenoid Therapeutics (TTX)

Paul E. Sporn

Co-Founder and Managing Director

4.8

40,000 users